Goldman Sachs Group Inc Invitae Corp Call Options Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding NVTA
# of Institutions
56Shares Held
7.66MCall Options Held
0Put Options Held
0-
State Of Wyoming Cheyenne, WY3.65MShares$00.01% of portfolio
-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Green Alpha Advisors, LLC450KShares$00.0% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
-
Longitude (Cayman) Ltd. Grand Cayman, E9215KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...